Plain-English translation of NCT05340868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing how semaglutide, a medication that helps with weight loss and blood sugar control, works in people with obesity or prediabetes. Researchers want to understand why different people respond differently to this treatment and what role genetics plays in how well it works for each person.
Doctors have noticed that this medication works very well for some people but not as well for others, and they don't fully understand why. This study aims to discover genetic clues that might help predict who will benefit most from this treatment.
You likely qualify if…
You likely don't qualify if…
You'll visit the clinic five times over about 4 months. At your first visit, doctors will do blood tests and measure your body composition. At your second visit, you'll eat a test meal while researchers measure your response, then you'll start taking the medication. Over the next 12 weeks, you'll gradually increase your dose while keeping a diary of side effects, and researchers will continue monitoring your blood sugar, weight, and body composition with blood tests and body scans.
AI-generated summary from trial data · Aug 15, 2026 · Not medical advice
Poland